Random

FDA

Many Cancer Drugs Approved Without Proven Significant Benefit

Many Cancer Drugs Approved Without Proven Significant Benefit

The Trouble With Sunscreen Chemicals

The Trouble With Sunscreen Chemicals

Vicodin

Vicodin is Now in the Most Restricted Category of Drugs

Suzanne B. Robotti

FDA

Recent Drug Approval Highlights Less Stringent FDA Criteria

Time For The FDA To Get Tough On Off-Label Drug Promotion

Time For The FDA To Get Tough On Off-Label Drug Promotion

girl investigating the fda on her computer

MedShadow Articles

Inside the FDA Drug Development Process: The Limits of Clinical Trials in Preventing Side Effects

Daphne Berryhill

Why A Lack of FDA Oversight Can Be Hazardous To Your Skin

Lack of FDA Oversight on Dermatologic Devices is Hazardous

Pressure Building on FDA For More Rigorous Sunscreen Testing

Pressure Building on FDA for More Rigorous Sunscreen Testing

News FDA Quick Hits

Quick Hits: FDA Limits Use of Antibiotics Class, & More

Drug Recalls in America, woman reading letter

Drug Recalls in America: How They Work, Where They Fail, and How You Can Protect Yourself

Kristel Tjandra

A New Opioid Deterrent Falls Short For FDA

A New Opioid Deterrent Falls Short For FDA

Suzanne B. Robotti

FDA Requiring Long-Term Research of OxyContin Use

FDA Requiring Long-Term Research of OxyContin Use

Suzanne B. Robotti

Trump and the Undermining of the FDA

Trump and the Undermining of the FDA

Makary’s “Blind Spots” Offers Big Ideas — But Can He Deliver as FDA Commissioner?

Suzanne B. Robotti

How Imodium Became Appealing to Opioid Addicts

How Imodium Became Appealing to Opioid Addicts

Hangover Treatment Side Effects

FDA Committees Wary of OTC Hangover Remedy

FDA

FDA Yanks Approval of Cholesterol Drugs Over Lack of Benefit

1 Million Medical Device Injuries Hidden in FDA Database

1 Million Medical Device Injuries Hidden in FDA Database

Transforming U.S. Drug Policy, equitable healthcare

MedShadow Articles

Opinion: Transforming U.S. Drug Policy for Better Drug Safety

Suzanne B. Robotti

FDA Backlog Keeps Generics From Coming To Market

FDA Backlog Keeps Generics From Coming To Market

Load More

x